These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26536183)

  • 1. [Not Available].
    Burmester GR
    Drug Res (Stuttg); 2015 Nov; 65 Suppl 1():S2. PubMed ID: 26536183
    [No Abstract]   [Full Text] [Related]  

  • 2. [Not Available].
    Strangfeld A
    Drug Res (Stuttg); 2015 Nov; 65 Suppl 1():S3-4. PubMed ID: 26536188
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular comorbidity in rheumatic and musculoskeletal diseases: Where we are and how can we move forward?
    Kitas GD; Dimitroulas T
    Int J Rheum Dis; 2021 Apr; 24(4):473-476. PubMed ID: 33817989
    [No Abstract]   [Full Text] [Related]  

  • 4. Health planning in rheumatic diseases. Elaboration of a master plan for rheumatic and musculoskeletal diseases of Catalonia.
    Larrosa M; Surís X; Pueyo MJ; Auleda J; de la Puente ML
    Reumatol Clin; 2012; 8(2):72-7. PubMed ID: 22341527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Musculoskeletal disorders--disease burden and challenges in the developing world.
    Gcelu A; Kalla AA
    S Afr Med J; 2015 Dec; 105(12):1070-1. PubMed ID: 26933718
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevalence of musculoskeletal pain and rheumatic diseases in the southeastern region of Mexico. A COPCORD-based community survey.
    Alvarez-Nemegyei J; Peláez-Ballestas I; Sanin LH; Cardiel MH; Ramirez-Angulo A; Goycochea-Robles MV
    J Rheumatol Suppl; 2011 Jan; 86():21-5. PubMed ID: 21196595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic impact of rheumatologic disorders.
    Sangha O; Stucki G
    Curr Opin Rheumatol; 1997 Mar; 9(2):102-5. PubMed ID: 9135912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fate of the patient with musculoskeletal disorders in Italy: an epidemiological insight.
    Cimmino MA; Salaffi F
    Clin Exp Rheumatol; 2007; 25(6):803-5. PubMed ID: 18173911
    [No Abstract]   [Full Text] [Related]  

  • 9. Exploring the role of rheumatic and musculoskeletal disease patient organisations during the COVID-19 pandemic: results from the REUMAVID study (phase 1).
    Garrido-Cumbrera M; Marzo-Ortega H; Christen L; Correa-Fernández J; Sanz-Gómez S; Navarro-Compán V;
    Clin Exp Rheumatol; 2022 May; 40(5):1062-1063. PubMed ID: 35084328
    [No Abstract]   [Full Text] [Related]  

  • 10. Correspondence on 'Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries'.
    Al Nokhatha S; MacEoin N; Conway R
    Ann Rheum Dis; 2021 Oct; 80(10):e170. PubMed ID: 33509797
    [No Abstract]   [Full Text] [Related]  

  • 11. How to manage rheumatic and musculoskeletal diseases - Preface.
    Stamm T; Moe RH
    Best Pract Res Clin Rheumatol; 2020 Apr; 34(2):101568. PubMed ID: 32762938
    [No Abstract]   [Full Text] [Related]  

  • 12. Complementary and alternative practices in rheumatology.
    Ramos-Remus C; Raut A
    Best Pract Res Clin Rheumatol; 2008 Aug; 22(4):741-57. PubMed ID: 18783748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of musculoskeletal complaints and use of health services in Asturias, Spain.
    Ballina Garcia FJ; Hernandez Mejía R; Martín Lascuevas P; Fernandez Santana J; Cueto Espinar A
    Scand J Rheumatol; 1994; 23(3):137-41. PubMed ID: 8016585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Socio-economic inequalities in occurrence and health care costs in rheumatic and musculoskeletal diseases: results from a Spanish population-based study including 1.9 million persons.
    Putrik P; Ramiro S; Orueta JF; Keszei A; Alonso Moran E; Nuño Solinis R; Boonen A
    Clin Exp Rheumatol; 2018; 36(4):589-594. PubMed ID: 29465359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of musculoskeletal disorders in southeastern Iran: a WHO-ILAR COPCORD study (stage 1, urban study).
    Sandoughi M; Zakeri Z; Tehrani Banihashemi A; Davatchi F; Narouie B; Shikhzadeh A; Mohammadi M; Jahantigh M; Shakiba M; Moulaei NA; Yousefi S; Rezazehi B; Shirzaei Sani E; Emamdadi A; Hoseynian M; Masoodian S; Shahbakhsh S
    Int J Rheum Dis; 2013 Oct; 16(5):509-17. PubMed ID: 24164837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research priority setting by young people with rheumatic musculoskeletal disease.
    McDonagh JE; Lunt L; Cresswell K; Parsons S; Tattersall R;
    Arch Dis Child; 2019 Feb; 104(2):204. PubMed ID: 30007947
    [No Abstract]   [Full Text] [Related]  

  • 17. Providing Rheum with a View.
    Mandell BF
    Med Clin North Am; 2021 Mar; 105(2):xv-xvi. PubMed ID: 33589112
    [No Abstract]   [Full Text] [Related]  

  • 18. Epidemiology of rheumatic musculoskeletal disorders in the developing world.
    Chopra A; Abdel-Nasser A
    Best Pract Res Clin Rheumatol; 2008 Aug; 22(4):583-604. PubMed ID: 18783739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Musculoskeletal clinical and cost-effectiveness outcome study group.
    Sadoghi P; Müller PE; Valderrabano V; Lidder S; Leithner A; Vavken P;
    Orthopedics; 2013 Mar; 36(3):174. PubMed ID: 23464933
    [No Abstract]   [Full Text] [Related]  

  • 20. [Germany's largest healthcare study NAKO with musculoskeletal examination program has started].
    Günther KP; Sander O; Schmidt CO; Specker C; Zink A
    Z Rheumatol; 2016 Oct; 75(8):757-759. PubMed ID: 27312469
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.